Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vsee Health (VSEE) EBIT (2023 - 2025)

Vsee Health (VSEE) has disclosed EBIT for 3 consecutive years, with -$2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT rose 96.47% year-over-year to -$2.1 million, compared with a TTM value of -$9.2 million through Sep 2025, up 84.52%, and an annual FY2024 reading of -$62.2 million, down 3217.21% over the prior year.
  • EBIT was -$2.1 million for Q3 2025 at Vsee Health, up from -$2.3 million in the prior quarter.
  • Across five years, EBIT topped out at $104060.0 in Q1 2024 and bottomed at -$58.3 million in Q3 2024.
  • Average EBIT over 3 years is -$6.4 million, with a median of -$932523.0 recorded in 2024.
  • Peak annual rise in EBIT hit 114.54% in 2024, while the deepest fall reached 16411.08% in 2024.
  • Year by year, EBIT stood at -$114831.0 in 2023, then tumbled by 2536.38% to -$3.0 million in 2024, then skyrocketed by 32.04% to -$2.1 million in 2025.
  • Business Quant data shows EBIT for VSEE at -$2.1 million in Q3 2025, -$2.3 million in Q2 2025, and -$1.8 million in Q1 2025.